Orders from 465 AED Free delivery from 965 AED Ready for pickup dead drop: collect in 5 min

Substances · Arylcyclohexylamines

DMXE (Deoxymethoxetamine)

C15H21NO CAS 2666932-45-0 Analytical reference material — not for human consumption
Preferred name
DMXE (Deoxymethoxetamine)
IUPAC name
2-(ethylamino)-2-(3-methylphenyl)cyclohexan-1-one
Parent CAS number (reference)
2666932-45-0
Molecular formula
C15H21NO
Molecular weight
231.33 g/mol
InChIKey
WIMLPRYZJQNQLE-UHFFFAOYSA-N
PubChem
CID 157010705
Source
PubChem
Verified synonyms & catalog abbreviations
Deoxymethoxetamine 3D-MXE DMXE 3-Me-2'-oxo-PCE

Matching Listings in This Store's Catalog

Verified Neurochemical & Toxicological Intelligence

DMXE (Deoxymethoxetamine)

3-Methyl-2'-oxo-PCE Dissociative (NMDA Antagonist) Arylcyclohexylamine
Verified PubChem & CAS Identity C15H21NO · CAS 2666932-45-0 · CID 157010705
Calibrated Physical Form Pure Crystalline / Analytical Powder (≥98%)
≥98% Analytical Purity Verified 231.33 g/mol
Peer-Reviewed & Agency Citations 2 · verified sources

Receptor Telemetry & Mechanism of Action

NMDA Uncompetitive Channel Blockade Primary
SERT / DAT Monoamine Reuptake Tone Moderate

Deoxymethoxetamine replacing MXE's 3-methoxy group with 3-methyl, preserving warm NMDA dissociation and monoaminergic warmth.

Biotransformation & Active Metabolites

Hepatic N-deethylation and ring hydroxylation.

Temporal Pharmacokinetics

3-Methyl-2'-oxo-PCE Dissociative (NMDA Antagonist) — Closest modern structural sibling to MXE, requiring ~20–25% higher milligram amounts (common 30–55 mg) with slightly shorter 3.5–5 h duration.

  1. Onset 20–45 min
  2. Peak Window 1–2.5 h
  3. Total Window 3.5–5 h
  4. Residual / Half-Life 3–6 h residual

Closest modern structural sibling to MXE, requiring ~20–25% higher milligram amounts (common 30–55 mg) with slightly shorter 3.5–5 h duration.

Quantitative Response Spectrum (Published Literature)

Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.

Threshold
8–15 mg
Cognitive & Sensory

Subtle threshold receptor activity (3-Methyl-2'-oxo-PCE Dissociative (NMDA Antagonist)).

Somatic & Autonomic

Minimal baseline autonomic shift.

Light
15–30 mg
Cognitive & Sensory

Mild, clear-headed expression of primary class profile.

Somatic & Autonomic

Light somatic modulation.

Common Reference
30–55 mg
Cognitive & Sensory

Full characteristic neurochemical and perceptual profile documented in literature.

Somatic & Autonomic

Moderate somatic relaxation, ataxia, or autonomic tone depending on class.

Strong
55–80 mg
Cognitive & Sensory

Pronounced intensity, cognitive/motor impairment, or deep immersion.

Somatic & Autonomic

Marked somatic load and heightened adverse-event sensitivity.

Heavy / Toxic Zone
85+ mg
Cognitive & Sensory

Amnesia, blackout, acute dysphoria, confusion, or anesthetic dissociation.

Somatic & Autonomic

High toxicity zone: severe motor loss, cardiovascular strain, or respiratory hazard.

Interaction Matrix & Critical Contraindications

Critical Hazard — Never Combine

Alcohol, Opioids (O-DSMT), Benzodiazepines, and GHB/GBL

Severe ataxia, unconsciousness, respiratory depression, and fatal vomiting aspiration.

MAOIs, MDMA, 4-MMC, 3-CMC, and Serotonin Releasers

SERT inhibition combined with monoamine releasers or MAOIs precipitates potentially fatal serotonin syndrome and hyperthermia.

Elevated Hazard — Avoid

Strong Stimulants (Cathinones, Cocaine, Amphetamines)

Compounds hypertension, tachycardia, manic disorientation, and psychotic episodes.

Caution / Receptor Attenuation

Cannabis & Psychedelics

Dramatically intensifies dissociation, confusion, and sensory immersion.

Structural Isomer & Sibling Comparison

Closest modern structural sibling to MXE, requiring ~20–25% higher milligram amounts (common 30–55 mg) with slightly shorter 3.5–5 h duration.

Physicochemical Stability & Storage

Form: White to off-white crystalline powder or fine crystals. · Soluble in water, ethanol, and saline.

Chemically stable when kept dry, sealed, and protected from light at room temperature.

Cross-Tolerance & Dependence Profile

Slowly decaying NMDA cross-tolerance shared across all arylcyclohexylamines (halves in ~3–7 days, full baseline 2+ weeks). Chronic frequent exposure carries documented urological/bladder epithelial toxicity.

Comprehensive Analytical & Toxicological Monograph

DMXE (Deoxymethoxetamine) (2-(ethylamino)-2-(3-methylphenyl)cyclohexan-1-one; CAS 2666932-45-0, PubChem CID 157010705) is a arylcyclohexylamine reference compound (C15H21NO, 231.33 g/mol) classified pharmacologically as a 3-Methyl-2'-oxo-PCE Dissociative (NMDA Antagonist). Deoxymethoxetamine replacing MXE's 3-methoxy group with 3-methyl, preserving warm NMDA dissociation and monoaminergic warmth. Hepatic N-deethylation and ring hydroxylation. In published observational and toxicological literature, threshold response is noted at 8–15 mg, light range at 15–30 mg, common reference range at 30–55 mg, strong intensity at 55–80 mg, and heavy/adverse territory at 85+ mg, with an onset of 20–45 min, peak window of 1–2.5 h, and total duration of 3.5–5 h (3–6 h residual). Closest modern structural sibling to MXE, requiring ~20–25% higher milligram amounts (common 30–55 mg) with slightly shorter 3.5–5 h duration. Critical contraindications include Alcohol, Opioids (O-DSMT), Benzodiazepines, and GHB/GBL, MAOIs, MDMA, 4-MMC, 3-CMC, and Serotonin Releasers.

Chemical Architecture & Structural Profile

DMXE (Deoxymethoxetamine) (2-(ethylamino)-2-(3-methylphenyl)cyclohexan-1-one) is a reference compound belonging to the Arylcyclohexylamines class, characterized by the molecular formula C15H21NO and a molar mass of 231.33 g/mol. The parent molecule is indexed under CAS registry number 2666932-45-0 and in the NCBI PubChem database as CID 157010705 (Standard InChIKey: WIMLPRYZJQNQLE-UHFFFAOYSA-N). This molecule shares its empirical formula (C15H21NO) with positional or structural isomers; unambiguous analytical identification requires matching the full IUPAC structure, CAS number (2666932-45-0), and spectroscopic profile.

Citations

Reference Toxicology & Safety Profile

In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), DMXE (Deoxymethoxetamine) is indexed within the Arylcyclohexylamines structural group. Arylcyclohexylamine derivative; toxicological literature highlights severe hazard interactions when combined with central nervous system depressants (alcohol, GHB/GBL, opioids, benzodiazepines). Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.

Citations

Analytical Use & Laboratory Notice

This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.

Citations